DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Niraparib in Tumors Metastatic to the CNS

Phase 2

Recruiting

Conditions: Metastatic Cancer
Central Nervous System Cancer

Interventions: Drug: Niraparib

First Posted Date: 2021-08-05

Last Posted Date: 2024-12-12

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT04992013

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Usability of a Perioperative Medication-Related Clinical Decision Support Application

Not Applicable

Completed

Conditions: Perioperative Medication Errors
Perioperative Adverse Medication Events

Interventions: Other: Electronic Clinical Decision Support Application

First Posted Date: 2021-08-03

Last Posted Date: 2021-08-03

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 40

Registration Number: NCT04988737

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Remote-delivered MBCT for SCAD Survivors

Phase 1

Completed

Conditions: Coronary Artery Disease
Acute Coronary Syndrome
Sleep
Anxiety

Interventions: Behavioral: MBCT

First Posted Date: 2021-07-30

Last Posted Date: 2024-05-16

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 19

Registration Number: NCT04983680

Locations: 🇺🇸
Mongan Institute: Health Policy Research Center, Boston, Massachusetts, United States

OCT Guided Trans Nasal Imaging of the Small Intestine in Adults

Not Applicable

Conditions: Environmental Enteric Dysfunction

Interventions: Device: TNIB Catheter

First Posted Date: 2021-07-30

Last Posted Date: 2024-05-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 30

Registration Number: NCT04984447

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Inqovi Maintenance Therapy in Myeloid Neoplasms

Phase 1

Recruiting

Conditions: Chronic Myelomonocytic Leukemia
Myelodysplastic Syndromes
Stem Cell Leukemia

Interventions: Drug: Inqovi

First Posted Date: 2021-07-28

Last Posted Date: 2024-03-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 22

Registration Number: NCT04980404

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

eCEASE to Support Treatment for Parental Tobacco Use

Not Applicable

Completed

Conditions: Second Hand Tobacco Smoke
Smoking Cessation
Tobacco Smoking

Interventions: Behavioral: iEHR + Navigator

First Posted Date: 2021-07-23

Last Posted Date: 2025-04-15

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 817

Registration Number: NCT04974736

Locations: 🇺🇸
The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Toolkit for Optimal Recovery After Orthopedic Injury

Not Applicable

Completed

Conditions: Acute Orthopedic Injury

Interventions: Behavioral: Toolkit for Optimal Recovery after Orthopedic Injury
Other: Minimally Enhanced Usual Care (MEUC)

First Posted Date: 2021-07-22

Last Posted Date: 2025-04-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 195

Registration Number: NCT04973696

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Tobramycin Injection to Prevent Infection in Open Fractures

Phase 3

Recruiting

Conditions: Fractures, Open
Surgical Site Infection
Wound Infection

Interventions: Drug: Tobramycin Injection

First Posted Date: 2021-07-16

Last Posted Date: 2025-05-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 600

Registration Number: NCT04964947

Locations: 🇺🇸
University of Kentucky, Lexington, Kentucky, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test

Phase 1

Completed

Conditions: Metabolic Diseases

Interventions: Diagnostic Test: Oral Glucose Tolerance Test
Drug: Placebo
Drug: Kisspeptin

First Posted Date: 2021-07-12

Last Posted Date: 2024-12-12

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 16

Registration Number: NCT04958109

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

LiverPAL: A Pilot Study of Inpatient Palliative Care for Patients With Advanced Liver Disease

Not Applicable

Completed

Conditions: Cirrhosis, Liver

Interventions: Behavioral: LiverPal Intervention

First Posted Date: 2021-07-07

Last Posted Date: 2023-06-27

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 25

Registration Number: NCT04953143

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy